Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Cytiva and Cellular Origins Advance Cell & Gene Therapy with Robotic Manufacturing
Friday, January 17, 2025Cytiva has partnered with Cellular Origins The collaboration aims to transform CGT production by integrating Cytivas automated Sefia platform with Cellular Origins robotic platform Constellation
Innovent and ASK Pharm Announce Approval of Limertinib for Lung Cancer Treatment
Friday, January 17, 2025Innovent Biologics and Jiangsu Aosaikang Pharmaceutical ASK Pharm have announced that the National Medical Products Administration NMPA in China has approved the New Drug Application NDA for limertinib
Eli Lilly's Omvoh® Gains FDA Approval for Crohn's Disease Treatment
Thursday, January 16, 2025Eli Lilly and Company has secured approval from the United States Food and Drug Administration FDA for Omvoh mirikizumabmrkz as a treatment for moderately to severely active Crohns disease in adults
Innovent Secures Breakthrough Therapy Designation for IBI343 in Pancreatic Cancer Treatment
Thursday, January 16, 2025Innovent Biologics has received Breakthrough Therapy Designation BTD from Chinas National Medical Products Administration NMPA for IBI Pancreatic cancer is a highly aggressive disease with a fiveyear survival rate
REGENXBIO and Nippon Shinyaku Partner to Develop Gene Therapies for MPS Diseases
Wednesday, January 15, 2025REGENXBIO and Nippon Shinyaku have formed an exclusive partnership to advance the development and commercialisation of RGX and RGX gene therapies targeting Mucopolysaccharidosis II MPS II or Hunter syndrome and Mucopolysaccharidosis I MPS I or Hurler...
ImmunoForge Secures Approvals for Key Clinical Trials in DMD Cardiomyopathy and Chronic Myeloid Leukaemia Treatment
Wednesday, January 15, 2025ImmunoForge has received regulatory approval for two significant clinical trials Cardiomyopathy is now a leading cause of mortality in DMD patients as advancements in respiratory care have extended lifespans DMDrelated cardiomyopathy results from imp...
Eisai and Biogen Announce FDA Acceptance of LEQEMBI® Application for Early Alzheimer’s Disease Treatment
Tuesday, January 14, 2025Eisai and Biogen have announced that the US Food and Drug Administration FDA has accepted the Biologics License Application BLA for LEQEMBI lecanemabirmb subcutaneous autoinjector SCAI for maintenance dosing
Simcere Zaiming Enters into Partnership with AbbVie to Develop Trispecific Antibody for Multiple Myeloma
Tuesday, January 14, 2025Simcere Zaiming and AbbVie have entered into a licensing agreement to advance the development of SIM a trispecific antibody currently undergoing Phase clinical trials for relapsed or refractory multiple myeloma MM in China and the United States
SN BioScience Secures FDA Clearance for SNB-101 Small Cell Lung Cancer Treatment
Monday, January 13, 2025SN BioScience has received Investigational New Drug IND clearance from the US Food and Drug Administration FDA to proceed with a Phase b clinical trial for its lead candidate SNB SNB is a novel anticancer therapy and the first nanoparticle formulatio...
Menarini Group and Insilico Medicine Enter into Agreement for AI-Discovered Preclinical Oncology Asset
Monday, January 13, 2025Menarini Group has announced a new licensing agreement with Insilico Medicine MEN developed through Insilicos AIdriven RD platform inhibits KAT and blocks endocrine receptor ER activity at the transcriptional level This mechanism offers the potential...
